The Use Case RISK PRINCIPE Infectiology Nosocomial infections - i.e. infections acquired in a hospital or a care facility - represent a great burden for the patients affected, the health care staff and [...] ensuring patient safety, particularly taking into account the increasing number of cases. The RISK PRINCIPE use case has the following goals: To develop algorithms and tools for risk prediction based on [...] according to relevant parameters in order to be able to act and react in a patient-oriented manner. RISK PRINCIPE relies on the expertise of various disciplines, including medical informatics, infection prevention
cohort investigating bronchial asthma and Principal Investigator in the disease area cystic fibrosis of the German Center for Lung Research. She is the local principal investigator for a number of industry
program in the Department of Hematology, Hemostasis, Oncology and Stem-Cell Translantation and a principal investigator in the Institute of Immunology (MHH). His work focusses on T cell responses in the
Phone: 0049 511 532 6116 Gross.Mechthild @ mh-hannover.de PD Dr. Loukia Spineli, Statistician Principal Investigator in Evidence Synthesis BSc Statistics and Insurance Science MSc Applied Statistics with
by midwife Professor Mechthild Gross. Other members of the team include PD Loukia Spineli PhD (Principal Investigator and Lecturer), Dr. Laura Zinsser (research associate) and Anne Hallet (Lecturer and
y, Prof. Gesine Hansen; since 2013 with teaching authorization (habilitation). Dr. Dittrich is Principal Investigator at the German Center for Lung Research for the diseases bronchial asthma and allergies
European Educational Workshop on MRD in AML and CLL October 02, 2023, Hilton Frankfurt Airport The principal aim of the workshop is a scientific exchange to build closer collaborations in the future and c [...] Initiative on CLL (ERIC) to exchange and harmonize MRD assessment between AML and CLL laboratories. The principal aim of the workshop is a scientific exchange to build closer collaborations in the future and c
Risk Of Severe COVID-19 Sponsor: University of Cologne Albertus-Magnus-Platz 50923 Cologne Germany Principal Coordinating Investigator : Priv.-Doz. Dr. med. Philipp Köhler Department I for Internal Medicine
Choose … Your Name: * Your email address (Please use MHH mail address): * Email address of your Principal Investigator (PI) (Please use MHH mail address): * Description: * I have taken note of the following
main focus on viral hepatitis, liver transplantation and hepatocellular carcinoma. He has been principal investigator in numerous clinical trials, focusing on antiviral therapy and immunotherapy of viral